What is SCN9A Protein?

The SCN9A protein, which belongs to the Sodium Channel, Voltage-Gated, Type IX, Alpha Subunit family, plays an integral role in human physiology. It is encoded by the SCN9A gene, one of the substantial representatives of the voltage-gated sodium channel gene family.

Discovered in the early 2000s through genome sequencing, the SCN9A gene plays a pivotal role in the development of certain human sensory conditions, making it a core focus within the biological and medical research community. Located on the short configuration (p) of chromosome 2 in band 24.3, the detailed gene locus is 2p24.3. Gene loci such as SCN9A help scientists identify the particular position of genes and genetic markers on specific chromosomes, hence playing a fundamental role in genetic mapping.

The SCN9A gene, stretching over 26 exons, encodes for a distinct isoform of the SCN9A protein, which originates from alternatively spliced transcript variants. The protein structure consists of four homologous domains (I-IV), each having six transmembrane segments (S1-S6). This assembly shapes the protein's central pore, allowing sodium ions to flow through the cell membrane in response to a voltage change.

Function of SCN9A protein

Functionally, the SCN9A protein is key in generating and transmitting electrical signals in neurons by mediating voltage-dependent sodium ion permeability of excitable membranes. This primarily involves pain signal transmission; hence, SCN9A function is intimately linked with pain perception. It functions as a tetrodotoxin-resistant voltage-gated sodium channel, and any disturbance or alterations in its function can lead to a spectrum of conditions related to aberrations in pain sensing.

SCN9A protein related signal pathway

One of the significant signal pathways related to SCN9A protein is the pain sensation pathway. Being a voltage-gated sodium channel, the SCN9A protein allows sodium ions to flow through the cell membrane during action potentials, transmitting pain signals from peripheral nerves to the central nervous system. Dysregulation or mutations affecting this protein could alter its function, leading to issues with the pain sensing mechanism.

SCN9A protein related diseases

Indeed, several diseases are associated with SCN9A protein. Mutations in the SCN9A gene have been linked to disorders like channelopathy-associated insensitivity to pain (CIP), paroxysmal extreme pain disorder (PEPD), and primary erythromelalgia (PE). Moreover, genetic studies also identified genetic variations of the SCN9A gene attributing a role in diabetes-related neuropathic pain, osteoarthritis, and susceptibility to common episodic headache disorders.

SCN9A protein's applications in biomedical

With respect to its biomedical applications, the SCN9A gene's critical role in pain susceptibilities has led to extensive research on tailored therapeutic interventions for related conditions. Disease-causing mutations of the SCN9A gene can provide new insights for the design of drugs to treat chronic pain conditions. Moreover, SCN9A protein is a promising therapeutic target for pain management, given its function in pain perception.

For instance, activating or inhibiting mutations in the SCN9A gene can create insensitivity or hypersensitivity to pain, respectively. This genetic insight opens opportunities for drug development targeting the SCN9A protein, which could provide more effective and personalized pain treatment by switching off pain-sensing nerves.

In conclusion, the SCN9A protein has significant relevance in human physiology, particularly in pain perception. Studies on this vital protein demonstrate our growing understanding of the genetic basis of diseases and the potential for developing targeted therapies. As we continue to unravel the intricacies of the SCN9A protein and its associated signal pathways, we move a step closer to discovering novel therapeutic strategies for a range of conditions associated with pain perception.

Our Featured Products

Cat.No.	Product Name	Species	Source (Host)	Tag
SCN9A-5270R	Recombinant Rat SCN9A Protein	Rat	Mammalian Cell	His
SCN9A-4929R	Recombinant Rat SCN9A Protein, His (Fc)-Avi-tagged	Rat	HEK293	His (Fc)-Avi
SCN9A-4929R-B	Recombinant Rat SCN9A Protein Pre-coupled Magnetic Beads	Rat	HEK293

Reference

• Xie, Xiao-hui & Tang, Jian-guang & Liu, Zhong-hua & Peng, Shui-jiao & Yuan, Zhuang-zhuang & Gu, Heng & Hu, Yi-qiao & Tan, Zhiping. (2021). Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain. Frontiers in Neuroscience. 15. 10.3389/fnins.2021.697167.